MINDY MOTTA: Open Payments
NPI 1306107784 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$108 in 5 payments from 3 companies in 2025. Trend: 2023 $206 · 2024 $101 · 2025 $108
Food & beverage: $108
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $41 |
| MILLICENT US INC | 2 | $36 |
| Astellas Pharma US Inc | 1 | $30 |
Products named: GEMTESA, Veozah, FEMRING, FEMLYV.
Industry payments across CA — which companies pay providers there.
